# Inhibikase Therapeutics, Inc. — Form D

Inhibikase Therapeutics, Inc. of Atlanta, GA, a company, filed a Form D exempt-offering notice with the SEC on 2024-06-04. The offering totals $8.0M. Industry: Pharmaceuticals.

## Offering

- Filed: 2024-06-04
- Form: D
- Accession: 0001750149-24-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $8.0M
- Remaining: $8.0M
- Investors: 1
- Date of first sale: 2024-05-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-515107

## Issuer

- Name: Inhibikase Therapeutics, Inc.
- CIK: 0001750149
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 3350 RIVERWOOD PARKWAY SE, SUITE 1900, Atlanta, GA, 30339
- Phone: 678-392-3419

## Officers, directors & promoters (14)

| Name | Role | Location |
| --- | --- | --- |
| Dennis H Berman | Director | Atlanta, GA |
| Gisele H Dion | Director | Atlanta, GA |
| Roy H Freeman | Director | Atlanta, GA |
| Paul H Grint | Director | Atlanta, GA |
| Milton H Werner | Director | Atlanta, GA |
| Garth H Lees-Rolfe | Executive Officer | Atlanta, GA |
| Milton H Werner | Executive Officer | Atlanta, GA |
| Joseph Frattaroli, C.P.A. | Executive Officer | Atlanta, GA |
| Paul Grint, M.D. | Director | Atlanta, GA |
| Milton H. Werner Ph.D | Director | Atlanta, GA |
| Milton H. Werner Ph.D | Executive Officer | Atlanta, GA |
| Dennis Berman | Director | Atlanta, GA |
| Gisele Dion | Director | Atlanta, GA |
| Roy Freeman M.D. | Director | Atlanta, GA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2023-02-07](https://search.stillhousedata.com/formd/0001209191-23-007563) | D | $4.2M | $4.2M |

## More

- [CIK 1750149 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1750149&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001750149-24-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.